Notably, there are classes of medications that can activate the MRGPRX2 receptor on mast cells, resulting in degranulation and release of inflammatory mediators that in turn result in reactions appearing similar to IgE-mediated reactions, although they are not triggered by allergy-specific antibodies (IgE).4 The gene discussed is IGHE; the disease is allergic disease.